French pharma will test investigational candidate alongside MSD’s Keytruda
News
Oxford start-up Base Genomics acquired by Exact Sciences
Acquisition will enable Base Genomics to accelerate clinical and commercial development
UK’s MHRA starts rolling review of Moderna’s COVID-19 vaccine
Process can help to reduce the time to authorisation of the vaccine
Enhertu bags US priority review for HER2+ gastric cancer
FDA action date for regulatory decision set during first quarter of 2021
Sanofi and GSK to provide COVID-19 vaccine doses to COVAX Facility
Agreement will see vaccine developers make available 200 million doses
Novartis’ rare renal disease candidate shows promise in phase II
Investigational oral treatment is being investigated in C3 glomerulopathy
Sensyne Health signs new NHS research agreement
Strategic research agreement announced with Milton Keynes University Hospital Foundation Trust
Bayer’s Nubeqa wins NICE prostate cancer backing
Drug authorised for use in non-metastatic castration-resistant prostate cancer
AstraZeneca resumes US phase III COVID-19 vaccine trial
Trial was paused in September following participant illness
Bayer to acquire cell and gene therapy specialist AskBio
Deal could be worth up to $4bn dependent on success milestones
Parkinson’s UK partners with UCL on phase II trial
Trial will investigate chemotherapy drug to alleviate hallucinations in people with Parkinson’s
Evgen scores full approval for COVID-19 trial launch
Investigational drug will be studied as treatment for ARDS in suspected COVID-19 patients
AZ presents new real-world chronic kidney disease data at ASN 2020
Initial key findings from the DISCOVER-Chronic Kidney Disease study revealed
BMS partners with Sensyne Health for rare blood disease research
Collaboration will involve applying machine learning for research into rare blood diseases
Merck KGaA, IAVI and Serum Institute link up to develop COVID-19 mAbs
Agreement will see partners develop SARS-CoV-2 neutralising monoclonal antibodies
